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Abstract. Pinta is a neglected, chronic skin disease that was first described in the sixteenth century in Mexico. The
World Health Organization lists 15 countries in Latin America where pinta was previously endemic. However, the current
prevalence of pinta is unknown due to the lack of surveillance data. The etiological agent of pinta, Treponema carateum,
cannot be distinguished morphologically or serologically from the not-yet-cultivable Treponema pallidum subspecies
that cause venereal syphilis, yaws, and bejel. Although genomic sequencing has enabled the development of molecular
techniques to differentiate the T. pallidum subspecies, comparable information is not available for T. carateum. Because
of the influx of migrants and refugees from Latin America, U.S. physicians should consider pinta in the differential
diagnosis of skin diseases in children and adolescents who come from areas where pinta was previously endemic and
have a positive reaction in serological tests for syphilis. All stages of pinta are treatable with a single intramuscular
injection of penicillin.
The endemic treponematoses, pinta, yaws, and bejel, are
caused by spiral-shaped, not-yet-cultivable bacteria of the genus
Treponema.1–3 These neglected infectious diseases (NIDs), for
which there are no vaccines, present a diagnostic dilemma to
physicians because their clinical manifestations must be differ-
entiated from those of other diseases that affect the skin.
Moreover, serological tests cannot differentiate the endemic
treponematoses from each other or from venereal syphilis,
which is caused by the closely related spirochete, Treponema
pallidum subspecies pallidum. Unlike venereal syphilis, the
endemic treponematoses are usually acquired by children or
adolescents living in poor rural communities in tropical climates
(see references 1 and 2 for maps showing the geographical
distribution of endemic treponematoses). Whereas venereal
syphilis has a global distribution and is transmitted primarily by
sexual activity, the endemic treponematoses are transmitted by
nonsexual, direct skin-to-skin contact with infectious lesions.
Pinta, also known as mal del pinto or carate, is the most
benign of the endemic treponematoses since it affects only the
skin.1–3 Pinta was first described in the sixteenth century in
the Aztec and Carib Amerindians by Spanish conquistadors and
missionaries.4 In the 1950s, there were an estimated 1 million
cases of pinta in Mexico, Central America, and northern South
America. Although pinta was most highly endemic in Mexico
and Columbia, cases declined in these countries due to treat-
ment campaigns and possibly due to improvements in living
standards, access to health services, and hygiene.4,5 The World
Health Organization (WHO) lists 15 countries in Latin America
where pinta was previously endemic. Because of the lack of
surveillance data, the current prevalence of pinta is unknown.
However, some findings suggest that pinta has not disappeared.
For example, in 1982 and 1983, clinical evidence of pinta was
discovered in 20% of the examined inhabitants of a remote vil-
lage in Panama.6 In 1987 and 1993, pinta cases were reported
in native Indians (Ticuna) living in the Amazon border region
of Brazil, Columbia, and Peru.7,8 Although the last reported
case of pinta in Cuba was in 1975, an active, early pinta lesion
was identified in a Cuban female who was visiting Austria in
1999.9 On the basis of these data, it is plausible that pinta has
remained endemic in some remote areas of Latin America
where access to health services is limited and living standards
have not yet risen.1,2
Like syphilis, pinta is classified into stages (see references 1–
3 for pictures of the clinical stages of pinta). The primary stage
is characterized by the presence of one or several papules or
erythematous scaly plaques that develop about 3 weeks after
infection. The body area most commonly affected is the exposed
skin of the extremities. The papule or plaque, which is teeming
with infectious treponemes, does not ulcerate, but expands to
a diameter of 10 cm or greater. Regional lymphadenopathy is
common. During early infection, serological tests for syphilis
(STS) may be negative for antibodies to nontreponemal
(cardiolipin) and treponemal antigens. Plaques may last for
months to years and pigmentary changes may be observed in
the plaques. The lesions may heal spontaneously or they may
persist and become indistinguishable from the lesions of sec-
ondary pinta.
The secondary stage usually appears several months after
the initial manifestations of the primary stage.1–3 Small dissem-
inated lesions known as “pintids” may coalesce into plaques.
The pintids change from an initial red color to brown, slate-
blue, black, or gray colors. Different pigmentation may occur
within a pintid. The secondary lesions can remain active and
infectious for a long time, leading to extensive depigmenta-
tion. STS are positive in the majority of untreated cases.
The late (tertiary) stage usually develops 2–5 years after ini-
tial infection and is characterized by pigmentary abnormalities
(i.e., from dyschromic treponeme-containing lesions to achromic
treponeme-free lesions), skin atrophy, and hyperkeratosis.1–3
The degree of lesion pigmentation can be different in the
same patient, resulting in a mottled appearance of the skin,
which can persist lifelong. Lesions may turn into various colors
(e.g., brown, gray-blue, or black). STS are positive in virtually
all untreated cases.
The etiological agent of pinta, Treponema carateum, was
not identified until over 30 years after the 1905 discovery
of the related agents of venereal syphilis and yaws.4,10–12
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Initially, it was thought that a pathogenic fungus caused pinta.
However, two observations suggested otherwise. First, labora-
tory studies of pinta patients’ sera showed that the Wassermann
test, an early STS, was positive in the majority of cases. Sec-
ond, treatments that were effective against syphilis (i.e.,
mercury and arsenicals) were also effective against pinta. In
August 1938, Sáenz and others10 using dark-field microscopy,
demonstrated the presence of spirochetes that were morpho-
logically indistinguishable from the T. pallidum subspecies in
exudate from a Cuban pinta patient’s lesions. Subsequently,
other investigators reported the presence of spirochetes in
pinta lesions. Because the presence of these bacteria was insuf-
ficient to prove causality, León-Blanco performed skin inocula-
tion experiments on himself and human volunteers with lesion
exudate that contained the spirochetes and succeeded in
reproducing the early manifestations of pinta.4,12 León-Blanco
also showed that some immunity to reinfection develops dur-
ing pinta. Patients with late-stage pinta could not be reinfected,
whereas patients whose early-stage pinta had been cured could
be reinfected. Furthermore, León-Blanco and Briceno Ross
and Iriarte demonstrated that syphilis and yaws patients,
respectively, were not immune to infection with pinta, despite
the antigenic similarity of the etiological agents.4,11,12
Because animal models are necessary to propagate the
T. pallidum subspecies for experimental studies, several inves-
tigators attempted to determine if laboratory animals could
be infected with T. carateum.11 León-Blanco and Oteiza13
reported infection of one of the four rabbits that they inocu-
lated intradermally with exudate from a pinta patient’s lesions.
However, they were unable to successfully passage T. carateum
from the rabbit’s lesion to other rabbits. Later, Kuhn and
others14 demonstrated that chimpanzees could be infected
intradermally and that these animals developed lesions similar
to those of pinta patients. Unfortunately, T. carateum isolates
are not available for study. Although phylogenetic data
obtained via genomic sequencing have enabled the develop-
ment of techniques to differentiate the T. pallidum subspecies,
comparable information is not available for T. carateum.1,2
Thus, despite the morphological and antigenic relatedness of
the agents of pinta and syphilis, molecular knowledge of
T. carateum is currently insufficient to warrant classification
of this spirochete as a T. pallidum subspecies.
Pinta can be treated with a single intramuscular injection
of long-acting benzathine penicillin (1.2 MU for adults; 0.6 MU
for children), which renders the lesions noninfectious in less
than 24 hours.1,3,11 Information is scant concerning the efficacy
of other antibiotics. Although early pinta lesions heal within
several months after penicillin administration, this treatment
cannot reverse the skin changes of late pinta that can stigma-
tize those who were infected.4 Penicillin treatment was the
mainstay for the “National Campaign to Eradicate Mal del
Pinto” conducted in Mexico (1960s) and for the WHO cam-
paign against the endemic treponematoses (1952–1964).1,2,4
A national campaign against yaws that was conducted in
Columbia in the 1950s resulted in an almost parallel decline
in the incidence of both yaws and pinta, even though pinta
was not specifically targeted.5 Despite the initial success of
these campaigns, the endemic treponematoses, particularly
yaws, have resurged due to the lack of sustained resources
and political will. The WHO has initiated a campaign to eradi-
cate yaws by 2020 that is based on mass treatment of endemic
communities with an oral dose of azithromycin, a macrolide
antibiotic with demonstrated efficacy against yaws.1,2,15 If
T. carateum is sensitive to azithromycin as is likely, this treat-
ment strategy could have a concomitant effect on pinta in areas
of Latin America where yaws and pinta may be co-endemic.
Moreover, if the endemic treponematoses were rolled into the
program area of the Pan American Health Organization’s
(PAHO’s) Strategic Plan (2014–2019) that targets selected
NIDs and focuses on strengthening national capacity for
screening, treatment, and surveillance of NIDs, this could
facilitate elimination of pinta and yaws in PAHO member
countries and would aid WHO’s yaws eradication campaign
(www.paho.org/hq/).
The possibility of importation of NIDs such as the endemic
treponematoses increases as record numbers of migrants and
refugees from Latin America continue to enter the United
States for economic or political reasons.2,3,16 Accordingly,
physicians should consider pinta in the differential diagnosis
of skin diseases for Latin American children and adolescents
who come from areas where pinta was previously endemic
and have a positive reaction in STS.3,16 This is critical to
guide treatment as well as to avoid the inadvertent psycho-
logical harm and legal ramifications that can result from
making an incorrect diagnosis of syphilis. Although pinta
may be a forgotten disease, it is unlikely to be extinct.9,17
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